rs12498609
|
TET2;TET2-AS1
|
MYELODYSPLASTIC SYNDROME
|
|
0.010 |
GeneticVariation |
BEFREE |
TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes.
|
30454965 |
2019 |
rs2454206
|
TET2;TET2-AS1
|
MYELODYSPLASTIC SYNDROME
|
|
0.010 |
GeneticVariation |
BEFREE |
We concluded that People with TET rs2454206 G/A genotype, TET2rs12498609 G/C genotype or ASXL1rs3746609 A/G genotype were related to lower prevalence of MDS.
|
30454965 |
2019 |
rs1221877686
|
TET2;TET2-AS1
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation |
BEFREE |
While there was a trend toward an earlier age at diagnosis, overall the clinicopathologic features of PCa were not significantly different in G84E carriers and non-carriers.
|
29181843 |
2018 |
rs1221877686
|
TET2;TET2-AS1
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation |
BEFREE |
While there was a trend toward an earlier age at diagnosis, overall the clinicopathologic features of PCa were not significantly different in G84E carriers and non-carriers.
|
29181843 |
2018 |
rs2454206
|
TET2;TET2-AS1
|
Childhood Acute Myeloid Leukemia
|
|
0.010 |
GeneticVariation |
BEFREE |
No difference in TET2 expression levels in AML with TET2 SNP rs2454206<sup>AA</sup> and TET2 SNP rs2454206<sup>AG/GG</sup> was detected, indicating that TET2 SNP rs2454206 status does not affect TET2 expression in pediatric AML.
|
29664232 |
2018 |
rs2454206
|
TET2;TET2-AS1
|
Leukemia, Myelocytic, Acute
|
|
0.010 |
GeneticVariation |
BEFREE |
No difference in TET2 expression levels in AML with TET2 SNP rs2454206<sup>AA</sup> and TET2 SNP rs2454206<sup>AG/GG</sup> was detected, indicating that TET2 SNP rs2454206 status does not affect TET2 expression in pediatric AML.
|
29664232 |
2018 |
rs72963007
|
TET2;TET2-AS1
|
Adult T-Cell Lymphoma/Leukemia
|
|
0.010 |
GeneticVariation |
BEFREE |
Strikingly, 9 of the 14 patients showed the same variation (SNP rs72963007), whose frequency in ATLL patients was significantly higher than that of an ethnically matched control population (13% vs. 5%).
|
28881727 |
2017 |
rs3733609
|
TET2;TET2-AS1
|
Myeloproliferative disease
|
|
0.010 |
GeneticVariation |
BEFREE |
A TET2 rs3733609 C/T genotype is associated with predisposition to the myeloproliferative neoplasms harboring JAK2(V617F) and confers a proliferative potential on erythroid lineages.
|
26843622 |
2016 |
rs3733609
|
TET2;TET2-AS1
|
Chronic myeloproliferative disorder
|
|
0.010 |
GeneticVariation |
BEFREE |
Altogether, we found a novel hereditary susceptible factor-TET2 rs3733609 C/T variant for the development of MPN, suggesting the variant may be partially responsible for the pathogenesis and accumulation of MPN.
|
26843622 |
2016 |
rs1391441
|
TET2;TET2-AS1
|
Lupus Nephritis
|
|
0.010 |
GeneticVariation |
BEFREE |
Four trans-eSNPs were observed to be associated with susceptibility to LN (P < 0.05), including ANKRD50 rs17008504, AGA rs2271100, PAK7 rs6056923, and TET2 rs1391441, while seven other trans-eSNPs showed marginal significant associations (0.05 < P < 0.1).
|
26509176 |
2015 |
rs2454206
|
TET2;TET2-AS1
|
Non-alcoholic Fatty Liver Disease
|
|
0.010 |
GeneticVariation |
BEFREE |
The p.Ile1762Val substitution (TET2-rs2454206) was associated with liver PPARGC1A-methylation and transcriptional levels, and Type 2 diabetes.Our results suggest that 5-hmC might be involved in the pathogenesis of NAFLD by regulating liver mitochondrial biogenesis and PPARGC1A expression.
|
26356709 |
2015 |
rs2454206
|
TET2;TET2-AS1
|
Diabetes Mellitus, Non-Insulin-Dependent
|
|
0.010 |
GeneticVariation |
BEFREE |
The p.Ile1762Val substitution (TET2-rs2454206) was associated with liver PPARGC1A-methylation and transcriptional levels, and Type 2 diabetes.Our results suggest that 5-hmC might be involved in the pathogenesis of NAFLD by regulating liver mitochondrial biogenesis and PPARGC1A expression.
|
26356709 |
2015 |
rs1368725108
|
TET2;TET2-AS1
|
Refractory cytopenia with multilineage dysplasia
|
|
0.010 |
GeneticVariation |
BEFREE |
We report a novel g.95805C>T, nonsense TET2 mutation, leading to a premature stop codon (p.Gln913*), in an adult patient with refractory cytopenia with multilineage dysplasia.
|
24301955 |
2013 |
rs10010325
|
TET2;TET2-AS1
|
Intelligence
|
A |
0.700 |
GeneticVariation |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |
rs11726786
|
TET2;TET2-AS1
|
Intelligence
|
T |
0.700 |
GeneticVariation |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |
rs1391440
|
TET2;TET2-AS1
|
Intelligence
|
C |
0.700 |
GeneticVariation |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Colorectal Neoplasms
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Malignant tumor of colon
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Colorectal Carcinoma
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Adenoma of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Malignant neoplasm of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |
rs1391441
|
TET2;TET2-AS1
|
Adenocarcinoma of large intestine
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Discovery of common and rare genetic risk variants for colorectal cancer.
|
30510241 |
2019 |